Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bitzer

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
Zeitschrift Fur Gastroenterologie|April 11, 2023
Sabrina Groß, Markus Follmann, Susanne Blödt, et al.
Human Gene Therapy|April 5, 2013
A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinomaSebastian Lange, Johanna Lampe, Sascha Bossow, et al.
Neuro-Oncology Advances|September 22, 2025
Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value FrameworkSylvia C Kurz, Mirjam Renovanz, Michael Bitzer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 21, 2017
Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-upSascha Kaufmann, Wolfgang M Thaiss, Maximilian Schulze, et al.
Bioinformatics (Oxford, England)|January 29, 2017
A comprehensive quality control workflow for paired tumor-normal NGS experimentsChristopher M Schroeder, Franz J Hilke, Markus W Löffler, et al.
Pathology Oncology Research : POR|August 29, 2025
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatmentJulia M Ott, Verena Gassenmaier, Michael Bitzer, et al.
Cancer Research|May 17, 2003
Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytesSorin Armeanu, Ulrich M Lauer, Irina Smirnow, et al.
Academic Radiology|October 8, 2010
Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenibDaniel Spira, Michael Fenchel, Ulrich M Lauer, et al.
AJR. American Journal of Roentgenology|December 24, 2009
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessmentOlga Maksimovic, Christina Schraml, Joerg T Hartmann, et al.
Cellular and Molecular Life Sciences : CMLS|May 12, 2010
Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophagesSabine Gröbner, Evelyn Fritz, Friederike Schoch, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Zeitschrift Fur Gastroenterologie|April 11, 2023
Sabrina Groß, Markus Follmann, Susanne Blödt, et al.
Human Gene Therapy|April 5, 2013
A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinomaSebastian Lange, Johanna Lampe, Sascha Bossow, et al.
Neuro-Oncology Advances|September 22, 2025
Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value FrameworkSylvia C Kurz, Mirjam Renovanz, Michael Bitzer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 21, 2017
Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-upSascha Kaufmann, Wolfgang M Thaiss, Maximilian Schulze, et al.
Bioinformatics (Oxford, England)|January 29, 2017
A comprehensive quality control workflow for paired tumor-normal NGS experimentsChristopher M Schroeder, Franz J Hilke, Markus W Löffler, et al.
Pathology Oncology Research : POR|August 29, 2025
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatmentJulia M Ott, Verena Gassenmaier, Michael Bitzer, et al.
Cancer Research|May 17, 2003
Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytesSorin Armeanu, Ulrich M Lauer, Irina Smirnow, et al.
Academic Radiology|October 8, 2010
Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenibDaniel Spira, Michael Fenchel, Ulrich M Lauer, et al.
AJR. American Journal of Roentgenology|December 24, 2009
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessmentOlga Maksimovic, Christina Schraml, Joerg T Hartmann, et al.
Cellular and Molecular Life Sciences : CMLS|May 12, 2010
Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophagesSabine Gröbner, Evelyn Fritz, Friederike Schoch, et al.
Pageof 19